Health Dashboard

Enter your password to continue

Incorrect password. Try again.

Health Optimization Dashboard

Tiffany Scott  ·  DOB 01/16/1979  ·  Last updated June 22, 2026

Jul 2025
Discovery — partial panel
Nov 2025
Expanded panel · amenorrhea
Mar 2026
Full picture · protocol launch
Jun 2026
Complete panel + DEXA + RMR
FSH not ordered for June 2026 — add to September draw. Ultrasensitive estradiol (LC/MS/MS, order code 30289) recommended given <30 result lacks precision for BHRT dosing.
Steroid precursor hormones
Pregnenolone
128 ng/dL
Ref: 22–237 · Target: 80+
53↑128
More than doubled — past target
DHEA-S
152 mcg/dL
Ref: 15–205
216→218↓152
Watch vs. pregnenolone trajectory
Magnesium, RBC
5.1 mg/dL
Ref: 4.0–6.4 · mid-range
Adequate
Thyroid
TSH
4.54 mIU/L
Target: 2.0–3.5
9.94↓4.91↓4.54
Improving — marginally high
TPO antibodies
276 IU/mL
Target: 250–325
468↓464→276
Within target
Free T4
1.0 ng/dL
Ref: 0.8–1.8
0.9→0.8↑1.0
In range
Free T3
3.2 pg/mL
Ref: 2.3–4.2
3.2→2.7↑3.2
Clean conversion
Reverse T3
8 ng/dL
Ref: 8–25
Optimal — no T4 pooling
Hormones — BHRT initiation urgent
Estradiol (E2)
<30 pg/mL
Follicular ref: 30–144
87↑97↓<30
BHRT urgent
Estrone (E1)
23 pg/mL
82↓23
Postmenopausal range
Total Estrogen
53 pg/mL
214↓53
Floor of range
Free Testosterone
2.0 pg/mL
Target: 4.0–6.0
4.6↓2.1↓2.0
BHRT indicated
Total Testosterone
23 ng/dL
35↓27↓23
Declining
SHBG
79 nmol/L
Target: 55–65
60↑82↓79
Elevated
LH
13.1 mIU/mL
28.3↓3.4↑13.1
Ovarian transition
FSH
—
Not ordered June 2026
Add to Sep draw
Progesterone
0.5 ng/mL
0.6→0.5
BHRT pending
Prolactin
8.9 ng/mL
Stable · normal
AMH
0.01 ng/mL
Ovarian reserve depleted
Iron & Anemia — primary rate limiter
Ferritin
19 ng/mL
Target: 70–100
27↑29↓19
Critical — iron loading active
RBC
3.59 M/uL
3.76↑4.25↓3.59
Normocytic anemia
Hemoglobin
11.3 g/dL
11.8↑13.3↓11.3
Below range
Hematocrit
34.4 %
37.2↑40.6↓34.4
Below range
Serum Iron
63 mcg/dL
131↓63
Low-normal
% Saturation
20 %
39↓20
In range, dropping
IGF-1 & Cortisol
IGF-1
244 ng/mL
Target: 180–250
157↑244
Within target · Z-score 0.2 → 1.2
Cortisol AM
10.7 mcg/dL
18.3↓10.7
Normalized
DEXA + RMR baseline complete — June 19, 2026. BF goal corrected to 18–20%. Prior 24.9% was a Hume Health BIA reading — kept as reference only.
DEXA — total body composition
Total body fat
33.4%
Target: 18–20%
Total mass
194.4 lbs
Fat mass
65.0 lbs
Lean mass
122.8 lbs
BMC (bone)
6.7 lbs
Fat-free mass
129.5 lbs
Regional breakdown
RegionFat %TotalFatLean
Arms34.1%26.0 lbs8.8 lbs16.2 lbs
Legs34.2%72.8 lbs24.9 lbs45.3 lbs
Trunk34.2%84.8 lbs29.0 lbs53.9 lbs
Android36.9%12.3 lbs4.5 lbs7.6 lbs
Gynoid36.5%30.9 lbs11.3 lbs19.1 lbs
Visceral fat & distribution
VAT volume
33.40 in³
Ideal: 0–52
Healthy range
A/G Ratio
1.00
Optimal: <1.0
At threshold
Bone density
1.442 g/cm²
T-score 3.6 · Z-score 1.8
Excellent
RMR — metabolic baseline
RMR
1,674 kcal/day
BMI
28.73
Maintenance
2,000–2,050 kcal
Suggested deficit
1,650–1,700 kcal
Lipids
Total Cholesterol
215 mg/dL
197191215
Monitor
LDL
139 mg/dL
122115139
Rising
HDL
61 mg/dL
616461
Stable
Triglycerides
63 mg/dL
574163
Pristine
Metabolic
Glucose
100 mg/dL
8197100
Borderline
HbA1c
5.3 %
5.45.55.3
Improving
Insulin
11.5 uIU/mL
Optimal
Homocysteine
7.3 umol/L
Excellent
Liver & kidney
AST / ALT
17 / 12
Pristine
eGFR
90–105
Excellent
Urine ACR
3 mg/g
No albuminuria
Omega fatty acids
EPA+DPA+DHA
4.6 % by wt
Optimal: ≥5.5
Upgrading omega-3
Omega-6/3 Ratio
8.6
In range
Autoimmune
ANA Screen
Positive
Watch and wait
ANA Titer
1:80
Recheck 6–12 mo
ANA Pattern
Nucleolar
Monitor
Inflammatory & CBC
hs-CRP
0.3 mg/L
Excellent
ESR
6 mm/h
Normal
WBC
3.5 K/uL
Low-stable
Platelets
291 K/uL
Normal
Vitamin D
38 ng/mL
Target: 60–80
3029↑35↑38
Below target
Selenium
142 mcg/L
Optimal
Zinc
67 mcg/dL
Low-normal
B12
374 pg/mL
MMA confirms adequate use
Folate
18.8 ng/mL
Normal
CoQ10
1.12 ug/mL
Adequate
Magnesium (serum)
1.8 mg/dL
Low-normal
Magnesium RBC
5.1 mg/dL
Adequate
Active stack as of June 2026. MOTS-c: previously used — replenishment deferred until anemia resolves.
Supplements
  • Selenium selenomethionine 200mcg · Thorne
  • Zinc bisglycinate Thorne
  • Vitamin D3 drops 10,000 IU · Thorne
  • Magnesium glycinate 200mg
  • NR + Quercetin Phytosome + Trans-Resveratrol 500/250/150mg · Reus Research
  • Creatine
  • Collagen powder
  • Ashwagandha powder
  • Baja Gold salt
  • Iron bisglycinate 108mg / 3 caps loading · Thorne
  • Boron 5mg · Pure TheraPro Rx
  • DIM + BioPerine 200mg
  • Resciency Mitochondrial & ATP 4 caps
  • Timeline Urolithin A 500mg / 2 softgels
  • Omega-3 high EPA 3 softgels
Peptides — active
Morning
KPV250mcg fasted
CJC/Ipamorelin300mcg fasted
Evening / Night
BPC-157250–300mcg
Tesamorelin0.5–1mg, empty stomach
CJC/Ipamorelin (PM)300mcg, no food 90min
Weekly
TB-500500mcg Mon + Thu
Paused / deferred
MOTS-creplenish after anemia resolves
5-Amino-1MQdeferred until anemia resolves
BHRT — pending initiation
Estradioltransdermal preferred
Progesteroneoral micronized
Testosterone1–5mg compounded cream
Log of peptide names, doses, and timing as recorded across protocol documents.
November 17, 2025
PeptideDoseTiming
KPV500 mcgMorning
BPC-157250 mcgTwice daily
TB-5005 mgWeekly, 6 weeks
Tesamorelin2 mgNightly
CJC-1295 / Ipamorelin300 / 300 mcgNightly
GHK-Cu (optional)100 mcgDaily
January 13, 2026 — Weekly checklist, Weeks 4–12
PeptideDoseTiming
KPV250 mcgMorning, daily
BPC-157250 mcgEvening, daily
Tesamorelin1 mg (40 units)Night, empty stomach
CJC-1295 / Ipamorelin300 mcgNight, empty stomach
TB-500500 mcgMon + Thu, non-training days
March 30, 2026 — Order + dosing schedule
PeptideDoseTiming
CJC-1295 / Ipamorelin15 unitsMorning, fasted
MOTS-c20 unitsPost-workout
Tesamorelin20 unitsEvening, before bed
BPC-15720 unitsEvening, before bed
TB-50020 unitsEvening, before bed
MOTS-c usage note
PeptideStatus
MOTS-cUsed March–May 2026 per above schedule. Replenishment deferred until anemia resolves.
Composite biological age
33–38
Chronological: 47
Established March 2026 · DEXA bone density (T-score 3.6, Z-score 1.8) reinforces young-skeletal-age component
CV age 32–35 VO2max 48.58 RHR 57 BP 116/79 Bone T-score +3.6 VAT 33.4 in³ (healthy)
Genetic variants
Risk variants confirmed
COMTDIM + Ca-D-glucarate w/ BHRT
MAO-ABHRT urgency ↑
AHCY + MAT1AMethylated B vitamins
SHMT1Methylfolate required
ACATContextualizes LDL
Normal variants
MTHFRNormal
MTR / MTRRNormal
BHMT / CBSNormal
VDRNormal
Body composition targets
Current weight
194.4 lbs
Target: 161–163 lbs
Current BF (DEXA)
33.4%
Target: 18–20%
Lean mass
122.8 lbs
Preserve
RMR
1,674 kcal/day
Deficit 1,650–1,700
September 2026 lab targets
TPO antibodies
276 → 250–325
Free Testosterone
2.0 → 4.0–6.0
SHBG
79 → 55–65
Ferritin
19 → 70–100
Vitamin D
38 → 60–80
TSH
4.54 → 2.0–3.5
FSH
Add to order
Clinical sequencing
1
Anemia correction — iron loading active, September confirmation
2
DEXA + RMR baseline — complete June 19, 2026
3
BHRT initiation — pregnenolone 128 supports proceeding
4
MOTS-c restock decision — after anemia resolves
5
September 2026 — full panel + FSH + consider ultrasensitive estradiol
6
New functional medicine / telehealth provider transition